Oncology Research Hub

Explore cutting-edge studies in tumor biology, molecular pathways, and clinical breakthroughs

Research Articles

The MURANO Trial: How a Fixed-Duration Therapy Revolutionized Treatment for Relapsed Blood Cancer

Learn how the groundbreaking MURANO trial established venetoclax plus rituximab (VenR) as a transformative fixed-duration therapy for relapsed/refractory chronic lymphocytic leukemia (CLL).

Levi James
Oct 15, 2025

Popular Articles